We are live on ! Find out more
EFTRW

eFFECTOR Therapeutics, Inc. Warrant
EFTRW

Delisted

EFTRW was delisted on the 2nd of July, 2024.

Back to rankings

38 hedge funds and large institutions have $5.23M invested in eFFECTOR Therapeutics, Inc. Warrant in 2021 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 4 increasing their positions, reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 4

46% more funds holding

Funds holding: 26 → 38 (+12)

44% more capital invested

Capital invested by funds: $3.62M → $5.23M (+$1.61M)

Holders
38
Holders Change
+12
Holders Change %
+46.15%
% of All Funds
0.66%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
4
Reduced
–
Closed
4
Calls
$294K
Puts
–
Net Calls
+$294K
Net Calls Change
+$132K

Top Buyers

Rank Fund Capital Flow
1
AC
Aristeia Capital
Connecticut
+$229K
2
QGA
Q Global Advisors
Texas
+$162K
3
GCL
Glazer Capital LLC
New York
+$133K
4
Citadel Advisors
Citadel Advisors
Florida
+$97.5K
5
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$90.1K

Top Sellers

Rank Fund Capital Flow
1
ECP
Empyrean Capital Partners
California
-$170K
2
PAMP
Polar Asset Management Partners
Ontario, Canada
-$102K
3
WA
Whitebox Advisors
Minnesota
-$26.9K
4
SCM
Saba Capital Management
New York
-$21K
Name Holding Trade Value Shares
Change 		Change in
Stake
PMAM
26
Picton Mahoney Asset Management
Ontario, Canada
$33K +$26.9K +33,332 New
EAM
27
Exos Asset Management
New York
$22K – – –
BI
28
Bulldog Investors
New Jersey
$20K +$2.35K +2,900 +17%
PI
29
PEAK6 Investments
Illinois
$17K – – –
HIM
30
HGC Investment Management
Ontario, Canada
$17K +$13.5K +16,666 New
Susquehanna International Group
31
Susquehanna International Group
Pennsylvania
$15K +$12.1K +14,945 New
PCM
32
Prelude Capital Management
New York
$12K +$9.75K +12,055 New
CAPTRUST Financial Advisors
33
CAPTRUST Financial Advisors
North Carolina
$5K +$3.76K +4,651 New
UBS Group
34
UBS Group
Switzerland
$1K +$441 +545 +757%
WAM
35
Wolverine Asset Management
Illinois
$1K +$1.51K +1,864 New
MI
36
MMCAP International
Cayman Islands
$151 – – –
Walleye Capital
37
Walleye Capital
New York
$10 +$8.09K +10,000 New
ECP
38
Empyrean Capital Partners
California
– -$170K -279,502 Closed
PAMP
39
Polar Asset Management Partners
Ontario, Canada
– -$102K -166,666 Closed
SCM
40
Saba Capital Management
New York
– -$21K -34,836 Closed
WA
41
Whitebox Advisors
Minnesota
– -$26.9K -33,333 Closed
1
2

EFTRW Hedge Fund Activity: Q2 2021 in Review

38 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in eFFECTOR Therapeutics, Inc. Warrant (EFTRW) for Q2 2021, worth a combined $5.23M — up 44% from $3.62M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new EFTRW positions and 4 closed out — a net gain of 12 holders — while 4 added to existing stakes and 0 trimmed.

The largest buyer was Aristeia Capital, opening a new position worth an estimated $229K. The largest seller was Empyrean Capital Partners, exiting entirely with an estimated $170K sold.

  • 38 institutional investors held eFFECTOR Therapeutics, Inc. Warrant (EFTRW) as of Q2 2021, up from 26 in Q1 2021.
  • Funds reported $5.23M of eFFECTOR Therapeutics, Inc. Warrant stock for Q2 2021, up 44% quarter-over-quarter.
  • 16 funds opened new eFFECTOR Therapeutics, Inc. Warrant positions in Q2 2021 and 4 closed out, a net change of +12 holders.
  • The largest eFFECTOR Therapeutics, Inc. Warrant buyer in Q2 2021 was Aristeia Capital, an estimated $229K added.
  • The largest eFFECTOR Therapeutics, Inc. Warrant seller in Q2 2021 was Empyrean Capital Partners, an estimated $170K sold.

Based on aggregated 13F filings for Q2 2021.